Scarica l'app Stockscreener
0.4502
8.40%
-0.0498
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - BioSpace
Co-Diagnostics Sets Date for Crucial Year-End 2024 Financial Results - StockTitan
Co-Diagnostics Inc.’s Securities Class Action - Global Legal Chronicle
Co-Diagnostics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
Co-Diagnostics wins dismissal of class action lawsuit - TipRanks
Federal Court Validates Co-Diagnostics' COVID Test ClaimsWhat This Legal Win Means - StockTitan
Co-Diagnostics (CODX) Projected to Post Earnings on Thursday - Defense World
Analyzing ResMed (NYSE:RMD) and Co-Diagnostics (NASDAQ:CODX) - Defense World
Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges - Investing.com Australia
Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - PR Newswire
Comparing Globus Medical (NYSE:GMED) and Co-Diagnostics (NASDAQ:CODX) - Defense World
Co-Diagnostics stock hits 52-week low at $0.65 amid market challenges - Investing.com Australia
Co-Diagnostics stock hits 52-week low at $0.65 amid market challenges By Investing.com - Investing.com South Africa
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Yahoo Finance
Infectious Disease Diagnostics Market (2024-2035): Trends, Growth Drivers, and Future Outlook - PharmiWeb.com
Looking For A Good Stock? Let This Co-Diagnostics Inc (NASDAQ: CODX) Analysis Help. - Stocks Register
Analyzing Co-Diagnostics (NASDAQ:CODX) and CVRx (NASDAQ:CVRX) - Defense World
CODX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Filed - ACCESS Newswire
Co-Dx withdraws FDA application to update COVID-19 test By Investing.com - Investing.com Australia
Co-Diagnostics Announces Intention To Submit Enhanced Version Of Covid-19 Test To FDA - Marketscreener.com
Co-Diagnostics Plans to Seek FDA Clearance for Enhanced Version of COVID-19 Test - Marketscreener.com
Co-Diagnostics Withdraws FDA Application for Covid Test -February 21, 2025 at 04:48 pm EST - Marketscreener.com
Co-Dx withdraws FDA application to update COVID-19 test - Investing.com India
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance - WV News
Co-Diagnostics (CODX) Stock Price, News & Analysis - MarketBeat
Co-Diagnostics Inc (CODX) stock analysis: A comprehensive overview - US Post News
Infectious Disease Diagnostics Market worth $31.5 billion by 2028 - WICZ
CODX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Class Action Filed - ACCESS Newswire
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Resul - GuruFocus.com
Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill - Nasdaq
Co-Diagnostics, Inc.: Live from Silicon Slopes - Nasdaq
CODX FINAL DEADLINE: ROSEN, A LEADING FIRM, Encourages Co-Diagnostics, Inc. Investors to Contact Firm Before Important August 17 Deadline in Securities Class Action Seeking Recovery of Investor LossesCODX - AccessWire
Quest Diagnostics (DGX) Stock Price, News & Analysis - MarketBeat
Jane Street Group LLC Makes New $55,000 Investment in Co-Diagnostics, Inc. (NASDAQ:CODX) - Defense World
CODX (Co-Diagnostics) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics faces potential Nasdaq delisting over share price - Investing.com
Co-Diagnostics faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - PR Newswire
Head to Head Contrast: Co-Diagnostics (NASDAQ:CODX) vs. Vasamed (OTCMKTS:VSMD) - Defense World
Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Rele - GuruFocus.com
Financial Review: Co-Diagnostics (NASDAQ:CODX) & Endologix (OTCMKTS:ELGXQ) - Defense World
Co-Diagnostics stock hits 52-week low at $0.79 amid market challenges - Investing.com
CoSara Diagnostics inaugurates new oligo facility in Ranoli, Gujarat - BSI bureau
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - Marketscreener.com
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - The Eastern Progress Online
Make in India: CoSara Diagnostics to open oligo facility in Ranoli - Medical Buyer
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - The Eastern Progress Online
Co-Diagnostics stock hits 52-week low at $0.85 amid market challenges - Investing.com Canada
0.64%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):